Beam Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Beam Therapeutics Stock Summary

Beam Therapeutics competes with Editas Medicine, Crispr Therapeutics, Caribou Biosciences, Verve Therapeutics, and Intellia Therapeutics. Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. Beam Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 507 people.

Beam Therapeutics Key Financial Ratios

Beam Therapeutics Key Balance Sheet Accounts

Beam Therapeutics Key Income Statement Accounts

Beam Therapeutics Key Cash Accounts

Beam Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Beam Therapeutics's current stock value. Our valuation model uses many indicators to compare Beam Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Beam Therapeutics competition to find correlations between indicators driving Beam Therapeutics's intrinsic value. More Info.Beam Therapeutics is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . At this time, Beam Therapeutics' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Beam Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Beam Therapeutics Systematic Risk

Today, most investors in Beam Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Beam Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Beam Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Beam Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Beam Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Beam Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Beam Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Beam Therapeutics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.